Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Open-market buys, last 90 days
$23,401
in 1 filing
Open-market sales, last 90 days
$5,107
in 3 filings

Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-05 Irish Jian Chief Executive Officer Sale −1,607 $1.60 $3K 333,770
2025-12-05 Irish Jian Chief Executive Officer Gift −228,462 335,377
2025-12-05 Thomas Brian C. Director Sale −3,830 $1.77 $7K 2,510,960
2025-12-05 Wein Matthew See Remarks Sale −199 $1.77 $353 115,031
2025-12-05 Wapnick Pamela Chief Financial Officer Sale −1,576 $1.77 $3K 188,956
2025-12-05 Irish Jian Chief Executive Officer Sale −1,602 $1.77 $3K 563,839
2025-12-01 Wapnick Pamela Chief Financial Officer Grant or award +120,000 $1.60 $192K 190,532
2025-12-01 Irish Jian Chief Executive Officer Grant or award +37,500 $1.60 $60K 354,441
2025-12-01 Irish Jian Chief Executive Officer Grant or award +211,000 $1.60 $338K 565,441
2025-12-01 Irish Jian Chief Executive Officer Grant or award · Stock Option (Right to Buy) +225,000 225,000
2025-12-01 Wein Matthew See Remarks Grant or award +96,000 $1.60 $154K 115,230
2025-09-05 Thomas Brian C. Director Sale −2,701 $1.81 $5K 2,514,790
2025-09-05 Wapnick Pamela Chief Financial Officer Sale −1,576 $1.81 $3K 70,532
2025-09-05 Irish Jian Chief Executive Officer Sale −1,602 $1.81 $3K 316,941
2025-09-05 Wein Matthew See Remarks Sale −199 $1.81 $360 19,230
2025-09-02 Reid Laurence Director Grant or award · Stock Option (Right to Buy) +42,000 42,000
2025-06-10 Eckhardt Juergen Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2025-06-10 Dere Willard H Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2025-06-10 BJERKHOLT ERIC Director Grant or award · Stock Option (Right to Buy) +8,572 8,572
2025-06-06 Wein Matthew See Remarks Sale −199 $1.75 $348 16,693

Page 2 of 6 · 101 trades